Triferic Pediatric Pharmacokinetic Protocol

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

November 1, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

January 31, 2017

Conditions
End Stage Renal Disease
Interventions
DRUG

Triferic

Trial Locations (9)

19803

Nemours/A. I. DuPont Hospital for Children, Wilmington

33021

Joe DiMagggio Children's Hospital/Memorial Regional Hospital, Hollywood

33136

Jackson Memorial Hospital, Miami

35233

Children's Hospital of Alabama, Birmingham

45229

Cincinnati Children's Hospital and Medical Center, Cincinnati

64108

Childrens Mercy Hospital, Kansas City

78229

University of Texas Health Science Center at San Antonio, San Antonio

92354

Loma Linda University Hospital, Loma Linda

94305

Lucile Packard Childrens Hospital, Stanford

All Listed Sponsors
lead

Rockwell Medical Technologies, Inc.

INDUSTRY

NCT02595437 - Triferic Pediatric Pharmacokinetic Protocol | Biotech Hunter | Biotech Hunter